The ECTRIMS Podcast

The European Committee for Treatment and Research in Multiple Sclerosis 83 - Predicting MS: Can Data Bring Us Closer to Personalised Care?

The ECTRIMS Podcast is a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.

00:00

Episodes

27 Aug 2026

12 Aug 2026

30 Jul 2026

08 Dec 2025

16 Jul 2026

02 Jul 2026

18 Jun 2026

03 Jun 2026

15 May 2026

22 Apr 2026

08 Apr 2026

19 Mar 2026

25 Feb 2026

07 Feb 2026

13 Jan 2026

13 Nov 2025

29 Oct 2025

15 Oct 2025

02 Oct 2025

26 Sep 2025

25 Sep 2025

24 Sep 2025

23 Sep 2025

19 Sep 2025

08 Sep 2025

17 Jul 2025

12 Jun 2025

21 May 2025

24 Apr 2025

27 Mar 2025

20 Feb 2025

16 Jan 2025

12 Dec 2024

27 Nov 2024

07 Nov 2024

24 Oct 2024

10 Oct 2024

09 Oct 2024

03 Oct 2024

23 Dec 2024

20 Sep 2024

19 Sep 2024

18 Sep 2024

17 Sep 2024

10 Sep 2024

04 Sep 2024

15 Aug 2024

23 Jul 2024

25 Jun 2024

The ECTRIMS Podcast

Episodes

Predicting MS: Can Data Bring Us Closer to Personalised Care?

How Technology Is Transforming Multiple Sclerosis Care

Should High-Risk Populations Be Screened for Multiple Sclerosis?

How well are we measuring cognition in MS?

How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis

Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation

Can the revised 2024 McDonald Diagnostic criteria solve the misdiagnosis problem in multiple sclerosis?

EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?

Fenebrutinib in Relapsing MS: FENhance Trial Results Explained

How MRI and OCT are Changing Multiple Sclerosis Diagnosis, Prognosis, and Treatment

Does the Label Given to My MS Disease Course Matter?

Rehabilitation in MS and the Case for Early Intervention

Fenebrutinib in PPMS: Insights from ACTRIMS Forum 2026

Harnessing the Gut Microbiome in MS: From Insight to Intervention

MS Nursing: Listening, Leadership, and the Role of AI in Patient Care

Why We Need to Talk More About Mental Health in MS

MS Research Through the Patient Lens: Key Takeaways from Patient Community Day 2025

Can We Repair Myelin in Multiple Sclerosis? Results from the CCMR-Two Trial

What's Next for MS Treatment? Key Takeaways from ECTRIMS 2025

New MS Research and Treatment Advances: Highlights from ECTRIMS 2025 | Day Two

Day 1 Highlights of ECTRIMS 2025

Pre-Day Highlights of ECTRIMS 2025

2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know

Genetics and MS: Recent Discoveries and Future Directions

The Expanding Role of Patient-Reported Outcomes in MS Research

Biomarkers in MS

BTK Inhibitors: The Tolebrutinib Trial Results

The Role of Diet in Managing MS

Autologous Haematopoietic Stem Cell Transplantation for MS

How Real-World Data Is Shaping MS Treatment

Fatigue in Multiple Sclerosis

Addressing Diversity in MS Research and Care

Paediatric Multiple Sclerosis

MS Prodrome: Implications and Future Research Directions

Future MS Therapeutics

MS Nurses at ECTRIMS 2024

Patient Community Day Highlights of ECTRIMS 2024: Part II

Patient Community Day Highlights of ECTRIMS 2024: Part I

Advancing MS Knowledge through the ECTRIMS Fellowship

Day 3 Highlights of ECTRIMS 2024

Day 2 Highlights of ECTRIMS 2024

Day 1 Highlights of ECTRIMS 2024

Pre-Day Highlights of ECTRIMS 2024

Episode 35: NMOSD and MOGAD Part II

Episode 35: NMOSD and MOGAD Part I

ECTRIMS-EAN Vaccination Consensus Statement (eanCast)

Environmental, Genetic, and Epigenetic Risk Factors in MS

Myelin plasticity and repair

Lifestyle Modifications in MS